A retrospective genomic analysis of drug-resistant strains of M. tuberculosis in a high-burden setting, with an emphasis on comparative diagnostics and reactivation and reinfection status
Kurt Wollenberg(National Institutes of Health), Valeriu Crudu, Nelly Ciobanu(Phthisiopneumology Institute "Chiril Draganiuc"), Michael A. Harris(National Institutes of Health), Darrell E. Hurt(National Institutes of Health), Alex Rosenthal(National Institutes of Health), Dumitru Chesov(Research Center Borstel - Leibniz Lung Center), Andrei Gabrielian(National Institutes of Health), Jessica Taaffe(National Institutes of Health), Alyssa Long(National Institutes of Health), Michael Tartakovsky(National Institutes of Health)
Cited by 20
Related Papers
DBAASP v3: database of antimicrobial/cytotoxic activity and structure of peptides as a resource for development of new therapeutics
|Nucleic Acids Research|2020|667
DBAASP v.2: an enhanced database of structure and antimicrobial/cytotoxic activity of natural and synthetic peptides
|Nucleic Acids Research|2015|241
PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis
|Science Translational Medicine|2014|158
The TB Portals: an Open-Access, Web-Based Platform for Global Drug-Resistant-Tuberculosis Data Sharing and Analysis
|Journal of Clinical Microbiology|2017|140